Overall Survival and Safety With Pemetrexed/Platinum ± Anti-VEGF Followed by Pemetrexed ± Anti-VEGF Maintenance in Advanced Nonsquamous Non–Small-Cell Lung Cancer: A Pooled Analysis of 4 Randomized Studies

MLA

Jong Seok Kim, et al. “Overall Survival and Safety With Pemetrexed/Platinum ± Anti-VEGF Followed by Pemetrexed ± Anti-VEGF Maintenance in Advanced Nonsquamous Non–Small-Cell Lung Cancer: A Pooled Analysis of 4 Randomized Studies.” Clinical Lung Cancer, vol. 23, May 2022, pp. 253–63. EBSCOhost, https://doi.org/10.1016/j.cllc.2021.10.010.

APA

Jong Seok Kim, Maria Teresa Rizzo, Patrick Peterson, & Edward B. Garon. (2022). Overall Survival and Safety With Pemetrexed/Platinum ± Anti-VEGF Followed by Pemetrexed ± Anti-VEGF Maintenance in Advanced Nonsquamous Non–Small-Cell Lung Cancer: A Pooled Analysis of 4 Randomized Studies. Clinical Lung Cancer, 23, 253–263. https://doi.org/10.1016/j.cllc.2021.10.010

Chicago

Jong Seok Kim, Maria Teresa Rizzo, Patrick Peterson, and Edward B. Garon. 2022. “Overall Survival and Safety With Pemetrexed/Platinum ± Anti-VEGF Followed by Pemetrexed ± Anti-VEGF Maintenance in Advanced Nonsquamous Non–Small-Cell Lung Cancer: A Pooled Analysis of 4 Randomized Studies.” Clinical Lung Cancer 23 (May): 253–63. doi:10.1016/j.cllc.2021.10.010.